A nano-luciferase expressing human coronavirus OC43 for countermeasure development
Description
The genetic diversity of the coronavirus (CoV) family poses a significant challenge for drug discovery and development. Traditional antiviral drugs often target specific viral proteins from specific viruses which limits their use, especially against
